Gonzalo G ómez, PhD. [email protected]

72
Gonzalo Gómez, PhD. [email protected] Madrid, Feb 16th, 2010. ::: An Introduction to Ingenuity Pathway Analysis. Course on Functional Analysis Bioinformatics Unit Structural Biology and Biocomputing program CNIO

description

Course on Functional Analysis. ::: An Introduction to Ingenuity Pathway Analysis. Madrid, Feb 16th, 2010. Bioinformatics Unit Structural Biology and Biocomputing program CNIO. Gonzalo G ómez, PhD. [email protected]. ::: Schedule. Introduction. Running into IPA Quick Search Toolbar - PowerPoint PPT Presentation

Transcript of Gonzalo G ómez, PhD. [email protected]

Page 1: Gonzalo G ómez, PhD.  ggomez@cnio.es

Gonzalo Gómez, PhD. [email protected] Gómez, PhD. [email protected]

Madrid, Feb 16th, 2010.Madrid, Feb 16th, 2010.

::: An Introduction to Ingenuity Pathway Analysis. ::: An Introduction to Ingenuity Pathway Analysis.

Course on Functional AnalysisCourse on Functional Analysis

Bioinformatics UnitStructural Biology and Biocomputing program

CNIO

Bioinformatics UnitStructural Biology and Biocomputing program

CNIO

Page 2: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Schedule.

1. Introduction.2. Running into IPA3. Quick Search4. Toolbar5. Gene Lists6. IPA Analysis7. Sharing Projects

Page 3: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Schedule.

1. Introduction.2. Running into IPA3. Quick Search4. Toolbar5. Gene Lists6. IPA Analysis7. Sharing Projects

Page 4: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Introduction.

Ingenuity Pathways Analysis (IPA)

Ingenuity Pathways Analysis v8.5Release Date: Feb 2010Customer Support: [email protected]://www.ingenuity.com/products/pathways_analysis.html

Integrated approach to “Omics” analysis :::

Page 5: Gonzalo G ómez, PhD.  ggomez@cnio.es

Ingenuity Pathways Analysis (IPA)

::: Introduction.

Page 6: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Introduction.

Ingenuity Pathways Analysis (IPA)

Page 7: Gonzalo G ómez, PhD.  ggomez@cnio.es

Ingenuity Pathways Analysis (IPA)

::: Introduction.

Types of analysis :::

Page 8: Gonzalo G ómez, PhD.  ggomez@cnio.es

Ingenuity Pathways Analysis (IPA)

::: Introduction.

Answering biological questions :::

Page 9: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Schedule.

1. Introduction.2. Running into IPA3. Quick Search4. Toolbar5. Gene Lists6. IPA Analysis7. Sharing Projects

Page 10: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Web Accession.

Ingenuity Pathways Analysis (IPA)

https://analysis.ingenuity.com/pa/

Page 11: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Running into IPA.

Project Manager

Menu.

Ingenuity Pathways Analysis (IPA)

Page 12: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Running into IPA.

File > Preferences ::: Ingenuity Pathways Analysis (IPA)

Page 13: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Help and tutorials.

Ingenuity Pathways Analysis (IPA)

Page 14: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Help and tutorials.

Help > Tutorials ::: Ingenuity Pathways Analysis (IPA)

Page 15: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA Networks Legend.

Help >Legend ::: Ingenuity Pathways Analysis (IPA)

Page 16: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA Networks Legend.

Network Explorer Tags Overlapping Networks Nodes and Edges

Help >Legend ::: Ingenuity Pathways Analysis (IPA)

Page 17: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Schedule.

1. Introduction.2. Running into IPA3. Quick Search4. Toolbar5. Gene Lists6. IPA Analysis7. Sharing Projects

Page 18: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Quick start searching a Single Gene.

Genes or chemicalsGenes/Chemicals associated with Functions/DiseasesGenes targeted by Drugs

GENES: Affymetrix, Agilent, Affymetrix SNP ID, Applied Biosystems, Code Link, Locus Link, Genbank,HUGO, Illumina, UniGene, RefSeq, Uniprot, etc.

DRUGS: Systematic names, IUPAC, CAS, Chemical formulaBrand Name.

Ingenuity Pathways Analysis (IPA)

Page 19: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Quick start exploring a Single Gene.

Ingenuity Pathways Analysis (IPA)

DescriptionGO AnnotationsHuman, Mouse, Rat detailsDatabase Information (Gene, RNA, Prot.)Functional rolesMutant InformationModifications and regulationDiseaseExpression and LocalizationPhysical interactionsLiterature entriesAdditional findings…

Which biological and disease processes are

most relevant to my genes of interest?

Page 20: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Explore and Advanced Search Options.

How do I query the Ingenuity Pathways Knowledge Base about specific genes, processes, diseases, drugs, famiies or subcellular locations?

Ingenuity Pathways Analysis (IPA)

Page 21: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Quick start exploring a Single Gene.

DescriptionGO AnnotationsHuman, Mouse, Rat detailsDatabase Information (Gene, RNA, Prot.)Functional rolesMutant InformationModifications and regulationDiseaseExpression and LocalizationPhysical interactionsLiterature entriesAdditional findings…

Ingenuity Pathways Analysis (IPA)

Page 22: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Quick start exploring a Single Gene.

Ingenuity Pathways Analysis (IPA)

Page 23: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Quick start exploring a Single Gene.

Interactive gene networks ::: Ingenuity Pathways Analysis (IPA)

Page 24: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Schedule.

1. Introduction.2. Running into IPA3. Quick Search4. Toolbar5. Gene Lists6. IPA Analysis7. Sharing Projects

Page 25: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Network Explorer Toolbar.

Ingenuity Pathways Analysis (IPA)

Page 26: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Network Explorer Toolbar.

Ingenuity Pathways Analysis (IPA)

Page 27: Gonzalo G ómez, PhD.  ggomez@cnio.es

Building a pathway :::

::: Exploring a Single Gene.

Ingenuity Pathways Analysis (IPA)

Page 28: Gonzalo G ómez, PhD.  ggomez@cnio.es

GrowPath explorer (shorstest path)ConnectTrim (remove)Keep (filter)Add Molecule/Relationship

Building pathways :::

::: Network Explorer Toolbar.

Also…quick access:

Ingenuity Pathways Analysis (IPA)

Page 29: Gonzalo G ómez, PhD.  ggomez@cnio.es

Building pathways :::

::: Network Explorer Toolbar.

Also…quick access:

Add molecule relationship

Ingenuity Pathways Analysis (IPA)

Page 30: Gonzalo G ómez, PhD.  ggomez@cnio.es

Expression valuesDrugFunctions and diseasesMy ListCanonical pathwayMy pathwayIngenuity tox listHighlight

Expression valuesDrugFunctions and diseasesMy ListCanonical pathwayMy pathwayIngenuity tox listHighlight

Overlaying pathways :::

::: Network Explorer Toolbar.

Ingenuity Pathways Analysis (IPA)

Page 31: Gonzalo G ómez, PhD.  ggomez@cnio.es

Designing pathways :::

::: Network Explorer Toolbar.

Ingenuity Pathways Analysis (IPA)

Page 32: Gonzalo G ómez, PhD.  ggomez@cnio.es

View options :::

::: Network Explorer Toolbar.

Ingenuity Pathways Analysis (IPA)

Page 33: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Schedule.

1. Introduction.2. Running into IPA3. Quick Search4. Toolbar5. Gene Lists6. IPA Analysis7. Sharing Projects

Page 34: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Exploring Gene Lists.

Gene, drug, AffyID1, Oxal*,CASP*,RefSeq X,cisplatin,…

::: Searching Lists.Ingenuity Pathways Analysis (IPA)

Page 35: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Gene Lists.

Saving a gene list :::Ingenuity Pathways Analysis (IPA)

Page 36: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Gene Lists.

Stored gene lists :::Ingenuity Pathways Analysis (IPA)

Page 37: Gonzalo G ómez, PhD.  ggomez@cnio.es

Creating pathways with Gene Lists :::

::: Gene Lists.

Etc.What regulatory effects relationships exists between the genes/proteins in my dataset?

Ingenuity Pathways Analysis (IPA)

Page 38: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Schedule.

1. Introduction.2. Running into IPA3. Quick Search4. Bar Tools5. Gene Lists6. IPA Analysis7. Sharing Projects

Page 39: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Analysis using IPA.

Expression data analysis

Toxicology analysis

Biomarker analysis

Metabolomics analysis

Ingenuity Pathways Analysis (IPA)

Page 40: Gonzalo G ómez, PhD.  ggomez@cnio.es

Core Analysis:Core Analysis: Core Analysis allows you to interpret datasets in the context of biological processes, pathways and molecular networks.

Core Comparison Analysis:Core Comparison Analysis: Core Comparison allows you to analyze changes in biological states across time and dosages. First run a core analysis on your multiple datasetsthat represent multiple timepoints or dosage treatments and use core Comparison Analysis to understand which biological processes and/or diseasesare relevant to each timepoint or dose.

Tox Analysis:Tox Analysis: The tox solution allows you to assess toxicity and safety of compounds of interest early in the development process and rapidly understand the relevant toxicity phenotypes and clinical pathology endpoints associated with a dataset.

Tox Comparison Analysis:Tox Comparison Analysis: Allows you to analyze changes in relevant toxicity phenotypes and clinical pathology endpointsacross time and dosages. First run a Tox Analysis on your multiple datasets that represent multiple timepoints or dosage treatments, use Tox Comparison Analysis to understand which tox functions and/or pathways are relevant to each timepoint or dose.

::: Types of Analysis.

Ingenuity Pathways Analysis (IPA)

Page 41: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Types of Analysis.

Biomarker Filter:Biomarker Filter: The biomarker analysis solution allows you to identify and prioritize the most relevant and promising molecular biomarker candidatesfrom datasets from nearly any step of the drug discovery process or any type of disease research. Use the Biomarker Filter to prioritize molecular biomarkercandidates based on contextual information such as mechanistic connection to diseases, detection in bodily fluids. Then, use the Biomarker Comparison Analysis to identify biomarker candidates that discriminate between or are common to a disease state and/or drug response.

Biomarker Comparison Analysis:Biomarker Comparison Analysis: To identify biomarker candidates that discriminate between or are common to a disease state and/or drug response. First run the Biomarker Filter to prioritize molecular biomarker candidates based on contextual information such as mechanistic connection to diseases, detection in bodily fluids, and use the Biomarker Comparison Analysis to identify biomarker candidates that discriminate between multiple samples.

Metabolomics Analysis:Metabolomics Analysis: The metabolomics analysis solution allows you to gain biological insight into cell physiology and metabolism from metabolite (endogenous chemicals)data.If you have multiple time points or dosage treatments, use Comparison Analysis to understand which biological processes and/or diseases are relevant to each time point or dose.

Metabolomics Comparison Analysis:Metabolomics Comparison Analysis: Comparison Core/ Metabolomics Analysis allows you to compare multiple experimental conditions in the context of biological processes, pathways and molecular networks

Ingenuity Pathways Analysis (IPA)

Page 42: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Importing data for analysis.

File format A :::- Single observation- .xls datasheet accepted- Up to 18 MB- 50000 row size limit

Ingenuity Pathways Analysis (IPA)

Page 43: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Importing data for analysis.

File format B :::

- Multiple observations (up to 10)- .xls datasheet accepted- Up to 18 MB- 50000 row size limit

Ingenuity Pathways Analysis 7.1 (IPA)

Page 44: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Sample Analyses.

Useful examples to learn how to deal with Ingenuity IPA…

Ingenuity Pathways Analysis (IPA)

Page 45: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Core Analysis.Expression Data Analysis.

Accession and workflow :::

Core Analysis:Core Analysis: Core Analysis allows you to interpret datasets in the context of biological processes, pathways and molecular networks.

Ingenuity Pathways Analysis (IPA)

Page 46: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Core Analysis.Expression Data Analysis.

Ingenuity Pathways Analysis (IPA)

Page 47: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Core Analysis.Expression Data Analysis.

Core analysis output :::

Right-tailed Fisher Exact test

Resultstabs

Ingenuity Pathways Analysis (IPA)

Page 48: Gonzalo G ómez, PhD.  ggomez@cnio.es

Right-tailed Fisher Exact test

::: Core Analysis.Expression Data Analysis.

Some statistics :::

2x2 Contingency Table.

= 0.05p < 0.05 + FDR are considered significant

Ingenuity Pathways Analysis (IPA)

Page 49: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Core Analysis.Expression Data Analysis.

Results tabs :::Networks

Functions(Bio)

Canonical Pathways

Lists(Tox)

Network explorer

Overlapping networks

Ingenuity Pathways Analysis (IPA)

Page 50: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Networks & Canonical Pathways

Which well characterized cell signaling and metabolicpathways are most relevant in my data?

Ingenuity Pathways Analysis (IPA)

Page 51: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Canonical Pathways

Ingenuity Pathways Analysis (IPA)

Page 52: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Core Comparison Analysis.Expression Data Analysis.

Core Comparison Analysis:Core Comparison Analysis: Core Comparison allows you to analyze changes in biological states across time and dosages. First run a core analysis on your multiple datasetsthat represent multiple timepoints or dosage treatments and use core Comparison Analysis to understand which biological processes and/or diseasesare relevant to each timepoint or dose.

Ingenuity Pathways Analysis (IPA)

Page 53: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Core Comparison Analysis.Expression Data Analysis.

Core comparison analysis output :::

Which functions and pathways are regulatedat different times, doses, or in different tissuesin my experiment?

Ingenuity Pathways Analysis (IPA)

Page 54: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Tox Analysis.Toxicology Analysis.

Tox Analysis:Tox Analysis: The tox solution allows you to assess toxicity and safety of compounds of interest early in the development process and rapidly understand the relevant toxicity phenotypes and clinical pathology endpoints associated with a dataset.

Ingenuity Pathways Analysis (IPA)

Page 55: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Tox Analysis.Toxicology Analysis.

IPA-Tox List Library :::

Ingenuity Pathways Analysis (IPA)

Page 56: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Tox Analysis.Toxicology Analysis.

IPA-Tox List Library :::

・ Toxicity lists are lists of genes that are known to be involved in a particular typeof toxicity.

・Manually-curated by Ph.D. Scientists

・ Relevant to drug metabolism

・ Cover oxidative stress response

・ Include panel of P450s, xenobiotic metabolism

・ Relevant to hepatic, renal, and cardiac toxicity and function

・ Contain fibrosis, cardiac hypertrophy and cell death

Ingenuity Pathways Analysis (IPA)

Page 57: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Tox Analysis.Toxicology Analysis.

Does this drug treatment cause any toxic effect?

Ingenuity Pathways Analysis (IPA)

Page 58: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Tox Analysis.Toxicology Analysis.

IPA-Tox analysis output :::

Resultstabs

Ingenuity Pathways Analysis (IPA)

Page 59: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Tox Analysis.Toxicology Analysis.

IPA-Tox analysis output :::

Toxicity Functions link expression data to clinical pathology endpoints for mechanistic hypothesis generation.

Categories cover a wide spectrum of well known drug induced injuries and pathologies useful for the drug discovery and development process, such as:

HepatoxicitySteatosis, Necrosis, Fibrosis, and moreCardiotoxicityCardiomyopathy, cardiac dilation, fibrosisNephrotoxicityTubular nephrosis, Phospholipidosis, kidney weight increase, etc.

Ingenuity Pathways Analysis (IPA)

Page 60: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Tox Comparison Analysis.Toxicology Analysis.

Ingenuity Pathways Analysis (IPA)

Page 61: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Tox Comparison Analysis.Toxicology Analysis.

Ingenuity Pathways Analysis (IPA)

Page 62: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Biomarker Analysis.Biomarker Analysis.

Are there any potential biomarkers in my samples?What are the unique and common potential biomarkers?

Ingenuity Pathways Analysis (IPA)

Page 63: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Biomarker Analysis.Biomarker Analysis.

Ingenuity Pathways Analysis (IPA)

Page 64: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Biomarker Comparison Analysis.Biomarker Analysis.

Ingenuity Pathways Analysis (IPA)

Page 65: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Biomarker Comparison Analysis.Biomarker Analysis.

Ingenuity Pathways Analysis (IPA)

Page 66: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Biomarker Comparison Analysis.Biomarker Analysis.

Ingenuity Pathways Analysis (IPA)

Page 67: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Metabolomics Analysis.Metabolomics Analysis

Ingenuity Pathways Analysis (IPA)

Page 68: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: IPA-Metabolomics Comparison Analysis.Metabolomics Analysis

Ingenuity Pathways Analysis (IPA)

Page 69: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Schedule.

1. Introduction.2. Running into IPA3. Quick Search4. Bar Tools5. Gene Lists6. IPA Analysis7. Sharing Projects

Page 70: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Sharing Projects.

File > Share > Invitations Manager :::

Accept or decline invitations…

Ingenuity Pathways Analysis (IPA)

Page 71: Gonzalo G ómez, PhD.  ggomez@cnio.es

::: Sharing Projects.

File > Share > Share Manager :::

Inviting to share projects…

Ingenuity Pathways Analysis (IPA)

Page 72: Gonzalo G ómez, PhD.  ggomez@cnio.es

Thanks [email protected]